Rachel Hanisch, Ph.D., M.P.H.

Cancer Program Manager (Contractor)
Genomic Epidemiology Branch, Epidemiology and Genomics Research Program

Telephone: (240) 781-3312
Fax: (240) 276-7906
E-mail: rachel.hanisch@nih.gov

  • Ph.D. – Epidemiology
    University of Washington
  • M.P.H. – Epidemiology
    Tulane University
  • B.S. – Zoology, Spanish
    University of Wisconsin-Madison


Dr. Rachel Hanisch recently joined the Genomic Epidemiology Branch (GEB) in the Epidemiology and Genomics Research Program (EGRP) as a contractor with Kelly Government Solutions. In this capacity, Dr. Hanisch is involved in both GEB and Program-wide activities related to patient engagement, consumer genetic testing, cancer registry development, and early life exposure topics.

Before joining EGRP, Dr. Hanisch was a Cancer Program Manager for the President’s Cancer Panel. She contributed to the work of the Panel by aiding in the process of gathering and synthesizing information on high-priority cancer topics that are identified by the Panel. This information ultimately aided in understanding potential solutions to these topics and framing actionable recommendations for the President and the public.

Dr. Hanisch has a special interest in global health efforts related to cancer screening and care.  Over the course of her career, Dr. Hanisch has worked on a variety of research and implementation initiatives involving cancer screening, care, and prevention in locations including Colombia, Ecuador, Senegal, and Tanzania. Dr. Hanisch also serves as a Visiting Professor at the University of Campinas School of Medical Sciences in Brazil where she is the principal lecturer of a class entitled “Scientific Writing for Non-Native English Speakers.”

Select Publications

Middleton DRS, Bouaoun L, Hanisch R, Bray F, Dzamalala C, Chasimpha S, Menya D, Mbalawa CG, N’Da G, Woldegeorgis MA, Njie R, Koulibaly M, Buziba N, Ferro J, Nouhou H, Ogunbiyi F, Wabinga HR, Chokunonga E, Borok MZ, Korir AR, Mwasamwaja AO, Mmbaga BT, Schuz J, McCormack VA. Esophageal cancer male to female incidence ratios in Africa: A systematic review and meta-analysis of geographic, time and age trends. Cancer Epidemiol. 2018 Apr;53:119-128.

Schaafsma T, Wakefield J, Hanisch R, Bray F, Schüz J, Joy EJ, Watts MJ, McCormack V. Africa’s oesophageal cancer corridor: geographic variations in incidence correlate with certain micronutrient deficiencies. PLoS One. 2015 Oct 8;10(10):e0140107.

Oreste-Munishi M, Hanisch R, Mapunda O, Ndyetabura T, Ndaro A, Kibiki G, Schuz J, McCormack V. Africa’s oesophageal cancer corridor: do hot beverages contribute? Cancer Causes Control. 2015 Oct; 26(10):1477-86.

Hanisch RA, Cherne SL, Sow PS, Winer RL, Hughes JP, Feng Q, Gottlieb GS, Toure M, Dem A, Kiviat NB, Hawes SE. Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia, and cancer in Senegal. Cancer Epidemiol. 2014 Aug;38(4):369-375.

Hanisch RA, Sow PS, Toure M, Dem A, Dembele B, Toure P, Winer RL, Hughes JP, Gottlieb GS, Feng Q, Kiviat NB, Hawes SE. Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa. J Clin Virol. 2013 Dec;58(4):696-702.

Cubasch H, Joffe M, Hanisch R, Schuz J, Neugut AI, Karstaedt A, Broeze N, van den Berg E, McCormack V, Jacobson JS. Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa. Breast Cancer Res Treat. 2013 Jul;140(1):177-86.